ArticleEuropean journal of medical research2025
Pirenzepine exhibits anti-prostate cancer activity and enhances checkpoint inhibitor-based immunotherapy by targeting STING.
Jinge Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.